Comparative description of immunological tests for tuberculous infection detection. Mass screening opportunities.
https://doi.org/10.21292/2075-1230-2016-94-5-5-16
Abstract
Goal: to evaluate efficiency of various immunological tests (tuberculin tests, IGRA tests, skin tests containing proteins specific for M. tuberculosis – ESAT-6, CFP10) in the detection of tuberculous infection, their sensitivity, specificity and opportunities to be used for mass screening in children and adolescents.
Materials. 122 Russian and foreign publications have been analyzed including reviews and meta-analyses.
Results. The specificity of tuberculin testing is fairly low due mass BCG vaccination among children and adolescents, IGRA tests possess high specificity but can not be used for mass screening due to high costs, intravenous manipulations and need for the well-equipped laboratory. Skin tests with agents containing the same proteins as IGRA tests are highly specific, sensible and effective for mass screening. Detection rate of tuberculosis and post-tuberculous changes in children with positive reaction to these tests is significantly higher compared to those with positive reactions to Mantoux testing with 2 TU PPD-L.
About the Authors
L. V. Slogotskaya
Moscow Municipal Scientific Practical Center of Tuberculosis Control, Health Department of Moscow,;
Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
Doctor of Medical Sciences, Head of Research-Clinical Department, Professor of Phthisiology Department of Russian Medical Academy of Postgraduate Education,
10, Stronymka St., Moscow, 107014
E. M. Bogorodskaya
Moscow Municipal Scientific Practical Center of Tuberculosis Control, Health Department of Moscow,;
Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
Doctor of Medical Sciences, Director, Professor of Phthisiology Department of Russian Medical Academy of Postgraduate Education,
10, Stronymka St., Moscow, 107014
References
1. Аksenova V.А. Tuberculosis among children in Russia. Tub. i Sots. Znachimye Zabolevaniya, 2014, no. 5, pp. 6-14. (In Russ.)
2. Аksenova V.А., Baryshnikova L.А., Klevno N.I. et al. Novye vozmozhnosti skrininga i diagnostiki razlichnykh proyavleniy tuberkuleznoy infektsii u detey i podrostkov v Rossii.V kn.:Kozhnaya proba s preparatom Diaskintest – novye vozmozhnosti identifikatsii tuberkuleznoy infektsii. [New opportunities for screening and diagnostics of various manifestations of tuberculous infection in children and adolescents. In: Skin test with the use of Diaskintest – new opportunities for tuberculous infection identification]. Part 2, ch. 2, 2nd Edition, ed. by M.A. Platsev, Moscow, Shiko Publ., 2011, pp. 134-152.
3. Аleksandrova E.А., Morozova T.I. Tuberculosis in children of the tender age exposed to drug resistant tuberculosis in the place of their residence Tub., 2015, no. 5, pp. 26-27. (In Russ.)
4. Аksenova V.А., Baryshnikova L.А. et al. Screening in children and adolescents of III, IV and V health groups with the use of a new diagnostic test. Tub., 2015, no. 5. pp. 40-41. (In Russ.)
5. Baryshnikova L.А., Аksenova V.А., Fedorin I.M. Specific manifestations of tuberculosis in children and adolescents after preventing treatment in the past. Probl. Tub., 2009, no. 1, pp. 30-33. (In Russ.)
6. Bogorodskaya E.M., Belilovskiy E.M., Puchkov K.G. et al. Tuberculosis incidence in children of the tender age in the city of Moscow and factors influencing on it. Tub. i Sots. Znachimye Zabolevaniya, 2014, no. 5, pp. 16-23. (In Russ.)
7. Bogorodskaya E.M., Sevostianova T.А., Senchikhina O.Yu. et al. Tuberkulez u deteii i podrostkov. V. kn.: Protivituberkuleznaya rabota v gorode Moskve. Analitichesky obzor statisticheskhy pokazateley po tuberkulezu, ispolzuemykh v Rossiyskoy Federatsii 2012g. [Tuberculosis in children and adolescents. In: Tuberculosis control activities in the city of Moscow. Analytic review of tuberculosis statistic rates used in the Russian Federation in 2012]. Moscow, MNPTsBT Publ., 2013, pp. 64-78.
8. Borisov S.E., Lukina G.V., Slogotskaya L.V. et al. Screening and monitoring of tuberculous infection in rheumatologic patients, treated by genetically engineered biological agents. Tub., 2011, no. 6, pp. 42-50. (In Russ.)
9. Bocharova I.V., Demin А.V. Doklinicheskie issledovaniya spetsificheskoy aktivnosti preparata «Diaskintest». V kn.: Kozhnaya proba s preparatom Diaskintest – novye vozmozhnosti identifikatsii tuberkuleznoy infektsii. [Pre-clinical testing of specific activity of Diaskintest. In: Skin test with the use of Diaskintest – new opportunities for tuberculous infection identification]. Part 1, ch. 7, 2nd Edition, ed. by M.A. Platsev, Moscow, Shiko Publ., 2011, pp. 114-125.
10. Volchkova I.L., Kazimirova N.E., Pankratova L.E. Use of diaskintest for selection of children and adolescents with latent tuberculous infection for preventive treatment Tub., 2015, no. 5, pp. 64-65. (In Russ.)
11. Dolzhenko E.N. Use of tuberculous recombinant allergen (Diaskintest) in the detection of active tuberculosis in children. Tub., 2013, no. 6, pp. 28-29. (In Russ.)
12. Dolzhenko E.N., Sheykis E.G., Seregina I.V. Diagnostic opportunities of tuberculous recombinant allergen for screening for tuberculous infection in adolescents of Razyan Region Tub., 2015, no. 6, pp. 56-57. (In Russ.)
13. Kislichkin N.N., Furs S.M., Krasilnikov I.V. et al. Diagnostics of tuberculosis. Tuberculin or diaskintest – what one should choose? Epidemiol. i Infekts. Bolezni, 2014, no. 5, pp. 50-55. (In Russ.)
14. Korneva N.V., Starshinova А.А., Ovchinnikova Yu.E. et al. Comparison of results with 2TU Mantoux testing and Diaskintest in various manifestations of tuberculous infection. Tub., 2013, no. 6, pp. 49-50. (In Russ.)
15. Lozovskaya M.E., Belushkov V.B., Novik G.А. et al. Diagnostics of tuberculosis in children with allergic reactions and diseases basing on the immune-allergic tests. Tub., 2015, no. 7, pp. 84-85. (In Russ.)
16. Materialy Profilnoy komissii po spetsialnosti «Ftiziatriya» pri glavnom vneshtatnom detskom spetsialiste ftiziatre Minzdrava Rossii. [Materials of the Special Commission in Phthisiatry by the Chief Pediatric TB Doctor of the Russian Ministry of Health]. http://www.humanhealth.ru/
17. Meysner А.F., Ovsyankina E.S., Stakheeva L.B. Detection of tuberculosis in adolescents in Moscow. Probl. Tub., 2009, no. 1, pp. 40-45. (In Russ.)
18. Meysner А.F., Ovsyankina E.S., Stakheeva L.B. Tuberculin diagnostics in children. Latent tuberculous infection? Probl. Tub., 2008, no. 6, pp. 29-32. (In Russ.)
19. Mikhaylova Yu.V., Son I.M., Skachkova E.I. et al. Tuberculosis prevalence in children and adolescents in the Russian Federation (analysis of official statistic data). Probl. Tub., 2009, no. 1, pp. 5-10. (In Russ.)
20. Moiseeva N.N., Odinets V.S. Experience of using skin test with diaskintest in mass screening for tuberculosis Tub., 2015, no. 7, pp. 92-93. (In Russ.)
21. Ovsyankina E.S., Gubkina M.F., Ershova N.G. et al. The experience of using the skin test (Diaskintest®) for respiratory tuberculosis diagnostics in children and adolescent in a TB unit. Tub., no. 1. 2010, pp. 16-19. (In Russ.)
22. Ovsyankina E.S., Slogotskaya L.V., Gubkina M.F. Rekomendatsii po primeneniyu kozhnoy proby s preparatom allergen tuberkulezny rekombinantny 0,2 mgk v 0,1 ml rastvor dlya vnutrikozhnogo vvedeniya (Diaskintest®) dlya identifikatsii tuberkuleznoy infektsii u detey i dispansernogo nablyudeniya v protivotuberkuleznykh uchrezhdeniyakh. Metod. rekom. [Recommendations on using skin test with tuberculous recombinant allergen with 0.2 mcg in 0.1 ml if solution for intracutaneous administration (Diaskintest®) for tuberculous infection identification in children and dispensary follow-up in TB units. Guidelines]. Moscow, MNPTsBT Publ., 2010, 29 p.
23. Poddubnaya L.V., Shilova E.P., Stepchenko I.M. et al. Epidemiological factors and immunological tests when forming tuberculosis risk groups. Tub., 2015, no. 5, pp. 153-154. (In Russ.)
24. Sapozhnikova N.V., Istomina E.V., Starshinova А.А. et al. Detection of latent tuberculous infection among groups of the advanced risk of developing tuberculosis. Tub., 2015, no. 7, pp. 123. (In Russ.)
25. Slogotskaya L.V. Skin immunological tests in tuberculosis – past and present times. Tub., 2013, no. 5, pp. 39-46. (In Russ.)
26. Slogotskaya L.V. Effektivnost kozhnogo testa s allergenom tuberkuleznym, soderzhaschim rekombinantniy belok ESAT6 CFP10 v diagnostike, vyavlenii i opredelnii aktivnosti tuberkuleznoy infektsii. Diss. dokt. med. nauk. [Efficiency of skin test with tuberculous allergen containing recombinant protein of ESAT6 CFP10 for diagnostics, detection and defining of the tuberculous infection activity. Doct. Diss.]. Moscow, 2011, 45 p.
27. Slogotskaya L.V., Ivanova D.А., Kochetkov Ya.А. et al. Sravnitelnye resultaty kozhnogo testa s preparatom, soderzhaschim rekombinantny belok CFP10ESAT6 i laboratornogo testa QUANTIFERON. [Comparative results of the skin test with the recombinant protein of CFP10ESAT6 and the laboratory test of QUANTIFERON]. Tub., 2012, no. 10, pp. 27-33. (In Russ.)
28. Slogotskaya L.V., Ivanova D.А., Senchikhina O.Yu. et al. Comparative study of results of skin testing with tuberculous recombinant allergen and laboratory tests of QuantiFERON-GIT in children and adolescents suffering from tuberculous infection. Tub. i Sots. Znachimye Zabolevaniya, 2013, no. 2, pp. 45-50. (In Russ.)
29. Slogotskaya L.V., Kochetkov Ya.А., Senchikhina O.Yu. et al. Changes in skin test (diaskintest) in children when assessing the activity of tuberculosis infection. Tub., 2011, no. 2, pp. 59-63. (In Russ.)
30. Slogotskaya L.V., Kоchetkov Ya.А., Filippov А.V. Efficiency of the new skin test (Diaskintest) when detecting active and latent tuberculosis in adolescents exposed to tuberculosis. Vopr. Sovr. Pediatrii, 2011, vol. 10, no. 3, pp. 8-13. (In Russ.)
31. Slogotskaya L.V., Litvinov V.I., Kochetkov Ya.А. et al. Opportunities of new skin test of Diaskin in diagnostics of tuberculous infection in children. Voprosy Diagnostiki v Pediatrii, 2011, pp. 20-24. (In Russ.)
32. Slogotskaya L.V., Litvinov V.I., Filippov А.V. et al. Susceptibility of new skin test of Diaskintest® in case of tuberculous infection in children and adolescents. Tub., 2010, no. 1, pp. 10-15. (In Russ.)
33. Slogotskaya L.V., Ovsyankina E.S., Kochetkov Ya.А. et al. The incidence of tuberculous infection in children and adolescents – view over the century. Tub., 2011, no. 3, pp. 21-28. (In Russ.)
34. Slogotskaya L.V., Senchikhina O.Yu., Bogorodskaya E.M. Susceptibility of the test with tuberculous recombinant allergen containing the protein of CFP10-ESAT6 in new tuberculosis cases among children and adolescents in Moscow. Tub. i Sots. Znachimye Zabolevaniya, 2013, no. 1, pp. 37-44. (In Russ.)
35. Slogotskaya L.V., Senchikhina O.Yu., Nikitina G.V. et al. Efficiency of the skin test with tuberculous recombinant allergen in the detection of tuberculosis in children and adolescents in Moscow in 2013. Pediatr. Pharmakologiya, 2015, no. 1, pp. 99-103. (In Russ.)
36. Sotneva I.B., Pavlunin А.V. Use of diaskintest for mass screening of children and adolescents in Nizhegorodskaya Region in 2013. Tub., 2015, no. 6, pp. 173. (In Russ.)
37. Starshinova А.А., Korneva N.V., Аnaniev S.M. et al. Comparison of diagnostic value of immunological testing (T-SPOT.TB and Mantoux test with 2 TU) in the diagnostics of latent tuberculosis infection in children with allergy in their medical history. Tub., 2015, no. 7, pp. 133-134. (In Russ.)
38. Tuberkulez v Rossiyskoy Federatsii 2012, 2013, 2014 g. Аnaliticheskiy obzor statisticheskikh pokazateley, ispolzuemykh v Rossiyskoy Federatsii i v mire. [Tuberculosis in the Russian Federation in 2011, 2013. 2014. Analytic review of statistic rates used in the Russian Federation and in the world]. Moscow, 2015, 311 p.
39. Shilova M.V. Actual aspects of tuberculosis incidence in children. Med. Vestn., 2014, no. 8 (657), pp. 13. (In Russ.)
40. Aagaard C., Govaerts M., Meikle V. et al. Optimizing antigen cocktails for detection of Mycobacterium bovis in herds with different prevalences of bovine tuberculosis: ESAT6-CFP10 mixture shows optimal sensitivity and specificity. J. Clin. Microbiol., 2006, vol. 44, pp. 4326-4335.
41. Aggerbeck H., Giemza R., Joshi P. Randomised Clinical Trial Investigating the Specificity of a Novel Skin Test (C-Tb) for Diagnosis of M. tuberculosis Infection. PLoS One, 2013, vol. 8, no. 5, pp. e64215.
42. Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin. Developm. Immunology, 2010, pp. 1-17.
43. Aissa K., Madhi F., Ronsin N. et al. Evaluation of a model for efficient screening of tuberculosis contact subjects. Am. J. Respir. Crit. Care Med., 2008, vol. 177, pp. 1041-1047.
44. Andersen P., Andersen A., Sorensen A. et al. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol., 1995, vol. 154, no. 7, pp. 3359-3372.
45. Andersen P., Doherty T., Pai M. et al. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol. Med., 2007, vol. 13, no. 5, pp. 175-182.
46. Andersen P., Munk M., Pollock J. et al. Specific immune – based diagnosis of tuberculosis. Lancet, 2000, vol. 356, pp. 1099-1104.
47. Arend S., Thijsen S., Leyten E. et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care Med., 2007, vol. 175, no. 6, pp. 618-627.
48. Arend S., van Meijgaarden K., de Boer K. et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J. Infect. Dis., 2002, vol. 186, pp. 1797-1807.
49. Bakir M., Millington K., Soysal A. et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann.Intern. Med., 2008, vol. 149, no. 11, pp. 777-787.
50. Bergstedt W., Tingskov P., Thierry-Carstensen B. et al. First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent. PLoS One, 2010, vol. 5, no. 6, pp. e11277.
51. Berkel G., Cobelens F., de Vries G. et al. Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int. J. Tuberc. Lung Dis., 2005, vol. 9, no. 3, pp. 310-316.
52. Brock I., Munk M., Kok-Jensen A. et al. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Tuberc. Lung Dis., 2001, vol. 5, pp. 462-467.
53. Brock I., Weldingh K., Lillebaek T. et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med., 2004, vol. 170, pp. 65-69.
54. Campainha S., Gomes T., Carvalho A. et al. Negative predictive value of TST and IGRA in anti-TNF treated patients. Eur. Respir. J., 2012.
55. Cauthen G., Snider D., Onorato I. Boosting of tuberculin sensitivity among Southeast Asian refugees. Am. J. Respir. Crit. Care Med., 1994, vol. 149, no. 6, pp. 1597-1600.
56. Comstock G., Edwards L., Philip R. et al. A comparison in the United States of America of two tuberculins, PPD-S and RT23. Bull. WHO, 1964, vol. 31, pp. 161-170.
57. del Corral H., Paris S., Marin D. et al. IFNgamma response to Mycobacterium tuberculosis, risk of infection and in household contacts of tuberculosis patients in Colombia. PLoS One, 2009, vol. 4, no. 12, pp. e8257.
58. Diel R., Goletti D., Ferrara G. et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J., 2011, vol. 37, pp. 88-99.
59. Diel R., Loddenkemper R., Meywald-Walter K. et al. Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot. TB Test in Contact Investigations for Tuberculosis. Chest, 2009, vol. 135, pp. 1010-1018.
60. Diel R., Loddenkemper R., Meywald-Walter K. et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am.J. Respir.Crit.Care Med., 2008, vol. 177, pp. 1164-1170.
61. Diel R., Loddenkemper R., Nienhaus A. Evidence – based comparison of commercial interferon-gamma release assay for detecting active TB: a metaanalysis. Chest, 2010, vol. 137, no. 4, pp. 952-968.
62. Dietrich J., Aagaard C., Leah R. et al. Exchanging ESAT6 with TB 10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J. Immunol., 2005, vol. 174, pp. 6332-6339.
63. Doherty T., Demissie A., Olobo J. et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J.Clin. Microbiol., 2002, vol. 40, no. 2, pp. 704-706.
64. Ewer K., Deeks J., Alvarez L. et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosisinfection in a school tuberculosis outbreak. Lancet, 2003, vol. 361, pp. 1168-1173.
65. Ferreira A., Ferreira M. de F., Macedo E. et al. BCG revaccination in school children: evolution of the lesion at the vaccination site between 48 hours and 10 weeks. J. Pediatr. (Rio J.), 2002, vol. 78, no. 4, pp. 289-294.
66. Flores-Villalva S., Suárez-Güemes F., Espitia C. et al. Specificity of the Tuberculin Skin Test Is Modified by Use of a Protein Cocktail Containing ESAT-6 and CFP-10 in Cattle Naturally Infected with Mycobacterium bovis. Clin.Vaccine Immunol., 2012, vol. 19, no. 5, pp. 797-803.
67. Friedland I. The booster effect with repeat tuberculin testing in children and its relationship to BCG vaccination. S. Afr. Med. J., 1990, vol. 77, no. 8, pp. 387-389.
68. Guld J., Waaler H., Sundaresan T. et al. The duration of BCG-induced tuberculin
69. sensitivity in children, and its irrelevance for revaccination. Results of two 5-year prospective studies. Bull World Health Organ., 1968, vol. 39, no. 5, pp. 829-836.
70. Higuchi K., Harada N., Fukazawa K. et al. Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb.), 2008, vol. 88, no. 3, pp. 244-248.
71. Hill P., Fox A., Jeffries D. et al. Quantitative T-cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin. Infect. Dis., 2005, vol. 40, pp. 273-278.
72. Horowitz H., Luciano B., Kadel J. et al. Tuberculin skin test conversion in hospital employees vaccinated with bacilleCalmette-Guerin: recent Mycobacterium tuberculosis infection or booster effect? Am.J.Infect.Control, 1995, vol. 23, no. 3, pp. 181-187.
73. Kik S., Franken W., Mensen M. et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur. Respir. J., 2010, vol. 35, pp. 1346-1353.
74. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest, 2007, vol. 131, pp. 1898-1906.
75. Lalvani A., Millington K. A. T cell-based diagnosis of childhood tuberculosis infection. Curr. Opin. Infect. Dis., 2007, vol. 20, pp. 264-271.
76. Lalvani A., Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br. Med. Bull., 2010, vol. 93, pp. 69-84.
77. Lamberti M., Uccello R., Monaco M. et al. Tuberculin skin test and Quantiferon test agreement and influencing factors in tuberculosis screening of healthcare workers: a systematic review and meta-analysis. J. Occup. Med. Toxicol., 2015, vol. 10, pp. 2. The electronic version of this article is the complete one and can be found online at: http://www.occup-med.com/content/10/1/2
78. Legesse M., Ameni G., Mamo G. et al. Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test.BMC Infect. Dis., 2011, vol. 11, pp. 89.
79. Legesse M., Ameni G., Mamo G. et al. Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia. BMC Infect. Dis., 2010, vol. 10, pp. 354,
80. Leung C., Yam W., Yew W. et al. T-Spot TB outperforms tuberculin skin test in predicting tuberculosis disease. AJRCCM, 2010, vol. 182, pp. 834-840.
81. Lienhardt C., Fielding K., Hane A. et al. Evaluation of the Prognostic Value of IFN-γ Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal. PLoS One, 2010, vol. 5, no. 5, pp. e10508.
82. Ling D., Zwerling A., Steingart K. et al. Immune-based diagnostics for TB in children: what is the evidence? Paediatr. Respir. Rev., 2011, vol. 12, no. 1, pp. 9-15.
83. Machingaidze S., Verver S., Mulenga H. et al. Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am.J. Respir.Crit. Care Med., 2012, vol. 186, no. 10, pp. 1051-1056.
84. Mack U., Migliori G., Sester M. et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur.
85. Respir. J., 2009, vol. 33, pp. 956-973.
86. Mazurek G., Jereb J., Vernon A. et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection. MMWR Recomm. Rep., 2010, vol. 59, pp. 1-25.
87. Mazurek G., Weis S., Moonan P. et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin. Infect. Dis., 2007, vol. 45, pp. 837-845.
88. Menzies D., Fanning A., Yuan L., Fitz Gerald J. Factors associated with tuberculin conversion in Canadian microbiology and pathology workers. Am.J. Respir. Crit. Care Med., 2003, vol. 167, no. 4, pp. 599-602.
89. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med., 2007, vol. 146, pp. 340-354.
90. Menzies R. Tuberculin skin testing. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York, Marcel Dekker, Inc., 2000, pp. 279-322.
91. Menzies R., Vissandjee B., Rocher I. et al. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann. Intern. Med., 1994, vol. 120, no. 3, pp. 190-198.
92. Metcalfe J., Everett C., Steingart K. et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: a systematic review and meta-analysis. J. Infect. Dis., 2011, vol. 204, suppl. 4, pp. 1120-1129.
93. Mori T., Sakatani M., Yamagishi F. et al. Specific detection of tuberculosis infection: an interferon-y-based assay using new antigens.Am. J. Respire Crit. Care Med., 2004, vol. 170, pp. 59-64.
94. Munk M., Arend S., Brock I. et al. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J. Infect. Dis., 2001, vol. 183, no. 1, pp. 175-176.
95. Nyboe J. The immediate effects of BCG revaccination. Bull World Health Organ., 1969, vol. 41, no. 1, pp. 63-73.
96. Olsen A., Williams A., Okkels L. et al. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect. Immun., 2004, vol. 72, pp. 6148-6150.
97. Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev. Mol. Diagn., 2006, vol. 6, pp. 4130-422.
98. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infections; an update. Ann. Intern. Med., 2008, vol. 149, pp. 177-184.
99. Pollock N., Mc. Adam A., Pai M. et al. Interferon γ-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. Clin. Chem., 2014, vol. 60, no. 5, pp. 714-718.
100. Rafiza S., Rampal K., Tahir A. Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia. BMC Infect. Dis., 2011, vol. 11, pp. 19.
101. Rangaka M., Wilkinson K., Glynn J. et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet. Infect. Dis., 2012, vol. 12, pp. 45-55.
102. Richards N., Nelson K., Batt M. et al. Tuberculin test conversion during repeated skin testing, associated with sensitivity to nontuberculous mycobacteria. Am. Rev. Respir. Dis., 1979, vol. 120, no. 1, pp. 59-65.
103. Richeldi L., Ewer K., Losi M. et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann. Intern. Med., 2004, vol. 140, pp. 709-713.
104. Salinas C., Pascual Erquicia S., Diez R. et al. Three-month course of rifampicin and isoniazid for the treatment of latent tuberculous infection. Med. Clin. (Barc), 2010.
105. Schluger N., Burzynski J. Recent advances in testing for latent TB. Chest, 2010, vol. 138, no. 6, pp. 1456-1463.
106. Sepulveda R., Burr C., Ferrer X. et al. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guerin at birth in Santiago, Chile. Pediatr. Infect. Dis. J., 1988, vol. 7, pp. 578-581.
107. Sepulveda R., Ferrer X., Latrach C. et al. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am. Rev. Respir. Dis., 1990, vol. 142, no. 1, pp. 24-28.
108. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv. Tuberc. Res., 1980, vol. 20, pp. 1-63.
109. Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull. Int. Union Tuberc., 1985, vol. 60, pp. 117-119.
110. Thompson N., Glassroth J., Snider D., Farer L. The booster phenomenon in serial tuberculin testing. Am. Rev. Respir. Dis., 1979, vol. 119, no. 4, pp. 587-597.
111. Topić R., Dodig S., Zoricić-Letoja I. Interferon-gamma and immunoglobulins in latent tuberculosis infection. Arch. Med. Res., 2009, vol. 40, no. 2, pp. 103-108.
112. Tornell E. Post-examination of BCG-material. Acta. Tuberc. Scand., 1947, vol. 21, pp. 241-273.
113. van Pinxteren L., Ravn P., Agger E. et al. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol., 2000, vol. 7, pp. 155-160.
114. van Zyl-Smit R., Pai M., Peprah K. et al. Within-subject variability and boosting of T cell IFN-{gamma} responses following tuberculin skin testing. Am. J. Respir. Crit. Care Med., 2009, vol. 180, pp. 49-58.
115. Vinton P., Mihrshahi S., Johnson P. et al. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect. Control, Hosp. Epidemiol., 2009, vol. 30, no. 3, pp. 215-221.
116. Vordermeier H., Chambers M., Cockle P. et al. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun., 2002, vol. 70, pp. 3026-3032.
117. Vordermeier H., Whelan А., Cockle Р. et al. Use of synthetic peptides derived from the antigens esat-6 and cfp-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol., 2001, vol. 8, pp. 571-578.
118. Watkins R., Brennan R., Plant A. Tuberculin reactivity and the risk of tuberculosis: a review. Int. J. Tuberc. Lung. Dis., 2000, vol. 4, pp. 895-903.
119. Weldingh K., Andersen P. ESAT-6/CFP10 skin test predicts disease in M. tuberculosis-infected guinea pigs. PLoS One, 2008, vol. 3, no. 4, pp. 1978.
120. Whelan A., Clifford D., Upadhyay B. et al. Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals. J. Clin. Microbiol., 2010, vol. 48, pp. 3176-3181.
121. Whelan A., Hope J., Howard C. et al. Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide. Infect. Immun., 2003, vol. 71, pp. 6420-6425.
122. Williams A., Hatch G., Clark S. et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinb.), 2005, vol. 85, pp. 29-38.
123. World Health Organization (2011) Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries. Policy Statement, pp. 1-61.
124. Yoshiyama T., Harada N., Higuchi K. et al. Use of the QuantiFERON-TB-Gold test for screening tuberculosis contacts and predicting active disease. Int. J. Tubercl. Lung Dis., 2010, vol. 14, no. 7, pp. 819-827.
Review
For citations:
Slogotskaya L.V., Bogorodskaya E.M. Comparative description of immunological tests for tuberculous infection detection. Mass screening opportunities. Tuberculosis and Lung Diseases. 2016;94(5):5-16. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-5-5-16
Views:
2721
Email this article 